idebenone has been researched along with Cirrhosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Idebenone treatment significantly corrected cardiac diastolic dysfunction and prevented mortality from cardiac pump failure induced by dobutamine stress testing in vivo, significantly reduced cardiac inflammation and fibrosis, and significantly improved voluntary running performance in mdx mice." | 3.75 | Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. ( Barzaghi, P; Buyse, GM; Courdier-Fruh, I; D'hooge, J; Erb, M; Herijgers, P; Jara, A; Meier, T; Mertens, L; Van Den Bergh, A; Van der Mieren, G; Verbeken, E, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buyse, GM | 1 |
| Van der Mieren, G | 1 |
| Erb, M | 1 |
| D'hooge, J | 1 |
| Herijgers, P | 1 |
| Verbeken, E | 1 |
| Jara, A | 1 |
| Van Den Bergh, A | 1 |
| Mertens, L | 1 |
| Courdier-Fruh, I | 1 |
| Barzaghi, P | 1 |
| Meier, T | 1 |
1 other study available for idebenone and Cirrhosis
| Article | Year |
|---|---|
Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Diastole; Dobutamine; Echocardiography; Fibro | 2009 |